Inventor · disambiguated record
Gool F. Patel
Also filed as: PATEL GOOL F
12 granted patents·1 pending application·127 citations·filing 1990–2010
91Inventor score
Top patents by PatentIndex Score
13 records- 0178US5777134A4-oxa and 4-thia steriodsMERCK & CO INC·Filed 1996·Granted Jul 7, 1998·24 cites·26 claims
- 0274US8178546B2Diaryltriazoles as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1ASTER SUSAN D·Filed 2010·Granted May 15, 2012·4 cites·5 claims
- 0370US5278159AAryl ester derivatives of 3-oxo-4-aza-androstane 17-β-carboxylates as 5-α-reductase inhibitorsMERCK & CO INC·Filed 1992·Granted Jan 11, 1994·20 cites·8 claims
- 0468US5710275A7β-substituted-4-aza-5α-androstan-3-ones as 5α-reductase inhibitorsMERCK & CO INC·Filed 1993·Granted Jan 20, 1998·22 cites·2 claims
- 0565US5998464A4-Oxa and 4-thia steroidsMERCK & CO INC·Filed 1996·Granted Dec 7, 1999·11 cites·14 claims
- 0658US5196411A17β-acyl-3-carboxy-androsta-3,5-dienes as testosterone 5α-reductase inhibitorsMERCK & CO INC·Filed 1991·Granted Mar 23, 1993·12 cites·3 claims
- 0757US5091380AN-monosubstituted adamantyl/norbornanyl 17β-carbamides of 3-carboxy-androst-3,5-dienes as testosterone 5α-reductase inhibitorsMERCK & CO INC·Filed 1990·Granted Feb 25, 1992·12 cites·5 claims
- 0853US5075450AIntermediates in the synthesis of 17β-acyl-3-carboxy-androsta-3,5-dienesMERCK & CO INC·Filed 1990·Granted Dec 24, 1991·8 cites·1 claims
- 0951US5693810A17 β-carboxanilides of 4-aza-5α-androstan-3-ones as 5α-reductase inhibitorsMERCK & CO INC·Filed 1993·Granted Dec 2, 1997·8 cites·3 claims
- 1047US7662846B2Selective spirocyclic glucocorticoid receptor modulatorsMERCK SHARP & DOHME·Filed 2004·Granted Feb 16, 2010·0 cites·5 claims
- 1147US5527807A7β-substituted-4-aza-5α-cholestan-3-ones as 5α reductase inhibitors useful in the prevention and treatment of hyperandrogenetic disordersMERCK & CO INC·Filed 1994·Granted Jun 18, 1996·6 cites·8 claims
- 1244US2008255216A1Diaryltriazoles as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase-1ASTER SUSAN D·Filed 2005·Application pending·0 cites
- 1339US7329683B211-β-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemiaMERCK & CO INC·Filed 2003·Granted Feb 12, 2008·0 cites·2 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →